1028820

Pfizer Inc — FEI 3004945409

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 8, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Peapack, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)